Area postrema removal abolishes stimulatory effects of intravenous interleukin-1β on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus

Brain Research Bulletin

Volumn 46, Issue 6, 1998, Pages 495-503

  Lee, Hong Yoon ^a   Whiteside, Michael B ^a   Herkenham, Miles ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Blood brain barrier; Circumventricular organ; Corticosterone; Corticotropin releasing hormone; Cytokine; In situ hybridization histochemistry; Norepinephrine; Nucleus of the solitary tract

Indexed keywords

CORTICOTROPIN; INTERLEUKIN 1BETA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; HISTOCHEMISTRY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; NEUROIMMUNOLOGY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS;

ADRENOCORTICOTROPIC HORMONE; AMYGDALA; ANIMALS; BRAIN CHEMISTRY; CEREBRAL VENTRICLES; CORTICOSTERONE; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-1; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEPTAL NUCLEI; SIGNAL TRANSDUCTION; SOLITARY NUCLEUS;

EID: 0345487015     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00045-8     Document Type: Article

References (63)

1. Alheid G.F., de Olmos J.S., Beltramino C.A. Amygdala and extended amygdala. Paxinos G. The rat nervous system. 2nd ed. 1994;495-578 Academic Press, San Diego.
2. Andreis P.G., Neri G., Belloni A.S., Mazzocchi G., Kasprzak A., Nussdorfer G.G. Interleukin-1β enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology. 129:1991;53-57.
3. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259:1991;988-996.
4. Barbanel G., Ixart G., Szafarczyk A., Malaval F., Assenmacher I. Intrahypothalamic infusion of interleukin-1β increases the release of corticotropin-releasing hormone (CRH 41) and adrenocorticotropic hormone (ACTH) in free-moving rats bearing a push-pull cannula in the median eminence. Brain Res. 516:1990;31-36.
5. Bataillard A., Sassard J. Cardiovascular effects of human recombinant interleukin-1β in conscious rats. Am. J. Physiol. 266:1994;R1148-R1153.
6. Berkenbosch F., Oers J.V., Rey A.D., Tilders F., Besedovsky H. Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science. 238:1987;524-526.
7. Brady L.S., Lynn A.B., Herkenham M., Gottesfeld Z. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J. Neurosci. 14:1994;4951-4964.
8. Broadwell R.D., Brightman M.W. Entry of peroxidase into neurons of the central and peripheral nervous system from extracerebral and cerebral blood. J. Comp. Neurol. 166:1976;257-283.
9. Buttini M., Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1β messenger RNA in rat brain microglial cells. Neuroscience. 65:1995;523-530.
10. Cechetto D.F., Calaresu F.R. Central pathways relaying cardiovascular afferent information to amygdala. Am. J. Physiol. 248:1985;R38-R45.
11. Chuluyan E.H., Saphier D., Rohn W.M., Dunn A.J. Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. Neuroendocrinology. 56:1992;106-111.
12. Ciriello J., Hochstenbach S.L., Roder S. Central projections of baroreceptor and chemoreceptor afferent fibers in the rat. Barraco R. Nucleus of the solitary tract. 1994;35-103 CRC Press, Boca Raton.
13. Cunningham E.T. Jr, Miselis R.R., Sawchenko P.E. The relationship of efferent projections from the area postrema to vagal motor and brain stem catecholamine-containing cell groups an axonal transport and immunohistochemical study in the rat . Neuroscience. 58:1994;635-648.
14. Cunningham E.T. Jr, Wada E., Carter D.B., Tracey D.E., Battey J.F., De Souza E.B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J. Neurosci. 12:1992;1101-1114.
15. Day H.E.W., Akil H. Differential patterns of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta implications for mechanism of action . Neuroendocrinology. 63:1996;207-218.
16. Dinarello C.A. Interleukin-1. Adv. Pharmacol. 25:1994;21-51.
17. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43:1988;429-435.
18. Dunn A.J., Chuluyan H.E. The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis dependence on the route of injection . Life Sci. 51:1992;219-225.
19. Edwards G.L., Ritter R.C. Lateral parabrachial lesions attenuate ingestive effects of area postrema lesions. Am. J. Physiol. 256:1989;R306-R312.
20. Ericsson A., Arias C., Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 17:1997;7166-7179.
21. 2 receptor (EP3 subtype) mRNA containing cells in the rat central nervous system. Soc. Neurosci. Abstr. 21:1995;98.
22. Ericsson A., Kovács K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
23. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain distribution, regulation, and relationship to sites of IL-1-induced cellular activation . J. Comp. Neurol. 361:1995;681-698.
24. Fleshner M., Goehler L.E., Hermann J., Relton J.K., Maier S.F., Watkins L.R. Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull. 37:1995;605-610.
25. Harbuz M.S., Stephanou A., Sarlis N., Lightman S.L. The effects of recombinant human interleukin (IL)-1α, IL-1β or IL-6 on hypothalamo-pituitary-adrenal axis function. J. Endocrinol. 133:1992;349-355.
26. Herbert H., Moga M.M., Saper C.B. Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat. J. Comp. Neurol. 293:1990;540-580.
27. Herkenham M. Influence of tissue treatment on quantitative receptor autoradiography. van Leeuwen F., Buijs R.M., Pool C.W., Pach O. Molecular neuroanatomy. 1988;111-120 Elsevier, Amsterdam.
28. Herkenham, M.; Lee, H. Y.; Baker, R. A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol., in press, 1998.
29. Hyde T.H., Miselis R.R. Effects of area postrema/caudal medial nucleus of solitary tract lesions on food intake and body weight. Am. J. Physiol. 244:1983;R577-R587.
30. Ishizuka Y., Ishida Y., Kunitake T., Kato K., Hanamori T., Mitsuyama Y., Kannan H. Effects of area postrema lesion and abdominal vagotomy on interleukin-1β-induced norepinephrine release in the hypothalamic paraventricular nucleus region in the rat. Neurosci. Lett. 223:1997;57-60.
31. Kabiersch A., Del Rey A., Honegger C.G., Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2:1988;267-274.
32. Kalia M., Fuxe K., Goldstein M. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J. Comp. Neurol. 233:1985;308-332.
33. Katsuura G., Arimura A., Koves K., Gottschall P.E. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am. J. Physiol. 258:1990;E163-E171.
34. Kovács K.J., Sawchenko P.E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 16:1996;262-273.
35. Lee H.Y., Herkenham M. Patterns of c-fos mRNA in rat brain following intravenous interleukin-1β Soc. Neurosci. Abstr. 21:1995;97.
36. Lee S., Rivier C. Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1β systemically or into the brain ventricles. J. Neuroendocrinol. 6:1994;217-224.
37. Loewy A.D. Central autonomic pathways. Loewy A.D., Spyer K.M. Central regulation of autonomic functions. 1990;88-103 Oxford University Press, New York.
38. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system involvement of the inducible proto-oncogenes fos and jun . Annu. Rev. Neurosci. 14:1991;421-451.
39. Norgren R., Smith G.P. Central distribution of the subdiaphragmatic vagal branches in the rat. J. Comp. Neurol. 273:1988;207-223.
40. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, Orlando.
41. Quan N., Sundar S.K., Weiss J.M. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49:1994;125-134.
42. Ritter S., McGlone J.J., Kelley K.W. Absence of lithium-induced taste aversion after area postrema lesion. Brain Res. 201:1980;501-506.
43. Rivest S. Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. In. J. Dev. Neurosci. 13:1995;135-146.
44. Rogers R.C., Hermann G.E. Central connections of the hepatic branch of the vagus nerve a horseradish peroxidase histochemical study . J. Auton. Nerv. Syst. 7:1983;165-174.
45. Rothwell N.J. Functions and mechanisms of interleukin-1 in the brain. Trends Pharmacol. Sci. 12:1991;430-436.
46. Sagar S.M., Price K.J., Kasting N.W., Sharp F.R. Anatomic patterns of FOS immunostaining in rat brain following systemic endotoxin administration. Brain Res. Bull. 36:1995;381-392.
47. Saphier D., Ovadia H. Selective facilitation of putative corticotropin-releasing factor-secreting neurons by interleukin-1. Neurosci. Lett. 114:1990;283-288.
48. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522-524.
49. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. Rev. 4:1982;275-325.
50. Shapiro R.E., Miselis R.R. The central neural connections of the area postrema of the rat. J. Comp. Neurol. 234:1985;344-364.
51. Shapiro R.E., Miselis R.R. The central organization of the vagus nerve innervating the stomach of the rat. J. Comp. Neurol. 238:1985;473-488.
52. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
53. Sugimoto Y., Shigemoto R., Namba T., Negishi M., Mizuno N., Narumiya S., Ichikawa A. Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience. 62:1994;919-928.
54. Swanson L.W., Kuypers H.G.J.M. The paraventricular nucleus of the hypothalamus cytoarchitectonic subdivisions and the organization of projections to the pituitary, dorsal vagal complex and spinal cord as demonstrated by retrograde fluorescence double-label methods . J. Comp. Neurol. 194:1980;555-570.
55. Tilders F.J.H., DeRijk R.H., Van Dam A.-M., Vincent V.A.M., Schotanus K., Persoons J.H.A. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins routes and intermediate signals . Psychoneuroendocrinology. 19:1994;209-232.
56. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Interleukin-1 stimulates ACTH release by an indirect mechanism which requires endogenous corticotropin releasing factor. Endocrinology. 121:1987;1580-1582.
57. Van Dam A.-M., Brouns M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588:1992;291-296.
58. Veening J.G., van der Meer M.J., Joosten H., Hermus A.R., Rijnnkels C.E., Geeraedts L.M., Sweep C.G. Intravenous administration of interleukin 1β induces Fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat. J. Chem. Neuroanat. 6:1993;391-397.
59. Wan W., Janz L., Vriend C.Y., Sorenson C.M., Greenberg A.H., Nance D.M. Differential induction of c-fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res. Bull. 32:1993;581-587.
60. Wan W., Wetmore L., Sorensen C.M., Greenberg A.H., Nance D.M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 34:1994;7-14.
61. Watkins L.R., Maier S.F., Goehler L.E. Cytokine-to-brain communication a review and analysis of alternative mechanisms . Life Sci. 57:1995;1011-1026.
62. Whitfield H.J. Jr, Brady L.S., Smith M.A., Mamalaki E., Fox R.J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain a detailed protocol . Cell. Mol. Neurobiol. 10:1990;145-157.
63. Yabuuchi K., Minami M., Katsumata S., Satoh M. Localization of type 1 interleukin receptor mRNA in the rat brain. Mol. Brain Res. 27:1994;27-36.